ニキビ薬市場は、2020年の20.7億ドルから2030年までに68.9億ドルに達し、今後数年間、つまり2020-30年のCAGRは12.76％と予想されます。
ニキビ薬は露出した皮膚や罹患した皮膚に直接塗布される治療薬であり、一般的に使用されるニキビ治療薬としては過酸化ベンゾイル、アゼライン酸、サリチル酸などがあります。にきびは深刻な皮膚病であり、顕著な心理的および感情的な問題を引き起こします。それらは皮膚科医や他の医療提供者によって治療されます。一般的に、にきびはホルモンによって生成される毛包脂腺単位の障害です。ホルモン類似体は、最も頻繁ににきび薬を活性化することができる薬です。毛嚢炎は、マラセチア種の異常増殖によって生成される最も一般的な薬物性ざ瘡であり、にきびに使用されるテトラサイクリンファミリーなどの広域抗生物質に続発することがよくあります。
目次
Contents
1. Executive Summary
2. Acne Drugs Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Acne Drugs Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Acne Drugs Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Billion Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Acne Drugs Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Inflammatory, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Non-Inflammatory, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Comedonal, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Post- Surgical, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Others, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Applications: Market Share (2020-2030F)
12.3.1. Hospital, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Online, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. E-pharmacies, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Retail, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Others, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Drug Type: Market Share (2020-2030F)
12.4.1. Antibiotics, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Anti-Microbial, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Hormonal Agents, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Topical Retinoid, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.5. Others, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
1. Sun Pharmaceuticals Industries Limited
1. Company Overview
2. Company Total Revenue (Financials)
3. Market Potential
4. Global Presence
5. Key Performance Indicators
6. SWOT Analysis
7. Product Launch
2. Johnson & Johnson
3. Almirall SA.
4. Teva Pharmaceuticals Industries Limited
5. Valeant Pharmaceuticals Industries Limited
6. Glaxo SmithKline Plc
7. Mylan N.V.
8. Mayne Pharma Group Limited
9. Nestle SA
10. Bausch Health Companies Inc.
11. Other Prominent Players
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
